Alternatives to Epeius Pharma

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

AI-driven digital twin of embryo development for cell-based therapies.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Developing polymer-based nanoparticles for targeted gene therapy delivery.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Compressing biology to develop the next generation of therapies.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Developing small molecules to treat sensory hyperexcitability disorders like pain and tinnitus.

Engineering scalable gene therapies for broader patient populations.

Developing a novel immune cell-based delivery platform for intracellular therapeutic protein transfer.

Scalable, one-time curative in-vivo gene editing therapies.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.